School of Psychology, University of Sydney, Sydney, Australia.
Translational Health Research Institute, School of Medicine, Western Sydney University, Penrith, Australia.
Int J Eat Disord. 2018 Aug;51(8):968-972. doi: 10.1002/eat.22873. Epub 2018 May 2.
Until recently, research into Chew and Spit (CHSP) behavior has predominantly focused on clinical samples, and little is known of its prevalence in the community. The current study aimed to bridge this gap by exploring CHSP features in a representative sample of the general population. We hypothesized that the point-prevalence of CHSP would be less than 1%; concurrent with other eating disorder symptomology, and associated with poorer health related quality of life (HRQoL).
Using the 2016, respondent-based, South Australian Health Omnibus Survey (HOS), data were collected on 3047 participants aged ≥15 years old. HRQoL was assessed with the Short-Form health-questionnaire-v1 (SF-12).
CHSP point prevalence was 0.4% (95% CI .23 to .69%; n = 13), and was more prevalent in people with compensatory disordered eating behaviors. The median age of those with CHSP was 39, and both mental and physical HRQoL were reduced compared with the general population (Mdn: MHQoL = 49; HRQoL = 50), with MHQoL being significantly lower in those with symptoms of a clinically diagnosable ED and concurrently engaged in CHSP (z = -2.33, p = .020).
Due to the low prevalence of CHSP, the reliability of inferential statistics may increase the chance of Type II errors, therefore, future studies should use larger samples. Although CHSP is not "common" in a wider community sample, its prevalence appears to be similar to other ED associated symptoms.
直到最近,对咀嚼和吐食(CHSP)行为的研究主要集中在临床样本上,而对其在社区中的流行程度知之甚少。本研究旨在通过探索一般人群中的代表性样本来填补这一空白。我们假设 CHSP 的时点患病率将低于 1%;与其他饮食障碍症状同时存在,并与较差的健康相关生活质量(HRQoL)相关。
使用 2016 年基于受访者的南澳大利亚健康综合调查(HOS)的数据,对 3047 名年龄≥15 岁的参与者进行了收集。HRQoL 采用简明健康调查问卷-1(SF-12)进行评估。
CHSP 的时点患病率为 0.4%(95%CI.23 至.69%;n=13),在有补偿性饮食障碍行为的人群中更为常见。CHSP 患者的中位年龄为 39 岁,与一般人群相比,心理健康和生理健康相关的生活质量均降低(中位数:MHQoL=49;HRQoL=50),同时存在 ED 症状且同时进行 CHSP 的患者 MHQoL 明显更低(z=-2.33,p=0.020)。
由于 CHSP 的患病率较低,推论统计的可靠性可能会增加 II 型错误的机会,因此,未来的研究应使用更大的样本。尽管 CHSP 在更广泛的社区样本中并不“常见”,但其流行程度似乎与其他与 ED 相关的症状相似。